Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation

Circulation

Volumn 106, Issue 10, 2002, Pages 1269-1274

  Makita, Naomasa ^a   Horie, Minoru ^a   Nakamura, Takeshi ^a   Ai, Tomohiko ^a   Sasaki, Koji ^a   Yokoi, Hisataka ^a   Sakurai, Masayuki ^a   Sakuma, Ichiro ^a   Otani, Hideo ^a   Sawa, Hirofumi ^a   Kitabatake, Akira ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Drugs; Genetics; Ion channels; Long QT syndrome; Torsade de pointes

Indexed keywords

CISAPRIDE; PROKINETIC AGENT; SODIUM CHANNEL; TETRODOTOXIN;

AGED; ARTICLE; BRUGADA SYNDROME; CASE REPORT; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; HUMAN CELL; LONG QT SYNDROME; MISSENSE MUTATION; PRIORITY JOURNAL; RISK FACTOR; SODIUM CURRENT; TORSADE DES POINTES;

AGED; AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE; CISAPRIDE; ELECTRIC CONDUCTIVITY; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ION CHANNEL GATING; LONG QT SYNDROME; MUTATION, MISSENSE; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; POTASSIUM CHANNELS; SODIUM CHANNELS;

EID: 0037015231     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000027139.42087.B6     Document Type: Article

References (31)

1. Molecular and cellular mechanisms of cardiac arrhythmias
2. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
3. + channel exhibiting novel molecular mechanisms of long QT syndrome
4. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
5. A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome
6. Molecular mechanism for an inherited cardiac arrhythmia
7. The Brugada syndrome: Clinical, genetic, cellular, and molecular abnormalities
8. Multiple mechanisms in the long-QT syndrome: Current knowledge, gaps, and future directions
9. A structural basis for drug-induced long QT syndrome
10. Kr potassium channels with HERG and is associated with cardiac arrhythmia
11. A common polymorphism associated with antibiotic-induced cardiac arrhythmia
12. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias
13. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel
14. Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1
15. 1 subunit
16. A mutant cardiac sodium channel with multiple biophysical defects associated with overlapping clinical features of Brugada syndrome and cardiac conduction disease
17. The cardiac sodium channel: Gating function and molecular pharmacology
18. + channel intermediate inactivation in Brugada syndrome
19. + channel
20. + channel by the gastrointestinal prokinetic agent cisapride
21. Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias
22. Pharmacogenetics and drug-induced arrhythmias
23. Taking the "idio" out of "idiosyncratic": Predicting torsades de pointes
24. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome
25. + channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome
26. Low penetrance in the long-QT syndrome: Clinical impact
27. Cardiac conduction defects associate with mutations in SCN5A
28. A sodium-channel mutation causes isolated cardiac conduction disease
29. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome
30. Molecular biology of sodium channels and their role in cardiac arrhythmias
31. + channel mutation causing both long-QT and Brugada syndromes